Clinical Trials

Showing trials with last updates posted in 2026.

NCT03048084 | RECRUITING | PHASE4
120 participants

Seizure Treatment in Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2018-02-01
Completion:
2028-01-01
Conditions
  • Glioma
Interventions
  • DRUG
No Results Yet
NCT02993068 | SUSPENDED | NA
5200 participants

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2017-04-18
Completion:
2028-04-18
Conditions
  • BARD1 Gene Mutation
  • BRCA1 Gene Mutation
  • BRCA2 Gene Mutation
  • BRIP1 Gene Mutation
  • Estrogen Receptor Negative
  • HER2/Neu Negative
  • MLH1 Gene Mutation
  • MSH2 Gene Mutation
  • MSH6 Gene Mutation
  • PALB2 Gene Mutation
  • PMS2 Gene Mutation
  • Progesterone Receptor Negative
  • RAD51C Gene Mutation
  • RAD51D Gene Mutation
  • Triple-Negative Breast Carcinoma
Interventions
  • OTHER
No Results Yet
NCT02159495 | ACTIVE_NOT_RECRUITING | PHASE1
31 participants

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2015-12-15
Completion:
2027-07-14
Conditions
  • Adult Acute Myeloid Leukemia in Remission
  • Acute Biphenotypic Leukemia
  • Early Relapse of Acute Myeloid Leukemia
  • Late Relapse of Acute Myeloid Leukemia
  • Recurrent Adult Acute Myeloid Leukemia
  • Secondary Acute Myeloid Leukemia
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Acute Myeloid Leukemia
  • Adult Acute Lymphoblastic Leukemia
  • Interleukin-3 Receptor Subunit Alpha Positive
  • Minimal Residual Disease
  • Refractory Acute Myeloid Leukemia
  • Untreated Adult Acute Myeloid Leukemia
Interventions
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT01959698 | ACTIVE_NOT_RECRUITING | PHASE1
29 participants

Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2014-04-17
Completion:
2020-06-01
Conditions
  • CD20 Positive
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Stage I Diffuse Large B-Cell Lymphoma
  • Stage II Diffuse Large B-Cell Lymphoma
  • Stage III Diffuse Large B-Cell Lymphoma
  • Stage IV Diffuse Large B-Cell Lymphoma
Interventions
  • DRUG
  • OTHER
  • BIOLOGICAL
NCT01123018 | COMPLETED
1 participants

Screening for Memory Studies

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-26
Start Date:
2007-06-30
Completion:
2023-12-31
Conditions
  • Memory Loss
  • Memory Deficits
  • Dementia
  • Alzheimer Disease
Interventions
  • BEHAVIORAL
No Results Yet
NCT00792948 | ACTIVE_NOT_RECRUITING | PHASE2
97 participants

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2009-09-01
Completion:
2016-06-01
Conditions
  • Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia
  • Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Adult L1 Acute Lymphoblastic Leukemia
  • Adult L2 Acute Lymphoblastic Leukemia
  • Adult T Acute Lymphoblastic Leukemia
  • Recurrent Adult Acute Lymphoblastic Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
NCT00575081 | RECRUITING
5000 participants

Physiological Brain Atlas Development

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-26
Start Date:
2006-08-31
Completion:
2027-08-31
Conditions
  • Parkinson's Disease
  • Obsessive Compulsive Disorder
  • Dystonia
  • Essential Tremor
  • Epilepsy
Interventions
  • DEVICE
No Results Yet
NCT00334815 | ACTIVE_NOT_RECRUITING | PHASE2
29 participants

Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2006-06-15
Completion:
2014-07-01
Conditions
  • Lung Adenocarcinoma
  • Lung Adenosquamous Carcinoma
  • Lung Large Cell Carcinoma
  • Lung Squamous Cell Carcinoma
  • Minimally Invasive Lung Adenocarcinoma
  • Stage IIIA Lung Non-Small Cell Cancer AJCC v7
  • Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Interventions
  • BIOLOGICAL
  • DRUG
  • RADIATION
NCT00066690 | COMPLETED | PHASE3
3066 participants

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-26
Start Date:
2003-12-17
Completion:
2014-05-31
Conditions
  • Estrogen Receptor Positive Breast Cancer
  • Progesterone Receptor Positive Tumor
  • Recurrent Breast Carcinoma
  • Stage IA Breast Cancer
  • Stage IB Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage IIIA Breast Cancer
Interventions
  • DRUG
  • OTHER
  • PROCEDURE
  • RADIATION
NCT07786207 | NOT_YET_RECRUITING
1000 participants

Knee Cartilage Repair Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-25
Start Date:
2026-09-30
Completion:
2034-03-31
Conditions
  • Knee Injuries
  • Joint Surface Knee Lesions
Interventions
  • DEVICE
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page